← Leaderboards
Jonathan R Pollack
Stanford University
$9,181,908
Attributed
$10,836,032
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,836,032 · 12
By mechanism
R01$8,369,978 · 6
U54$1,650,550 · 2
P30$524,830 · 2
P20$186,054 · 1
R03$104,620 · 1
Top collaborators
- Robert B West8 shared
- James D Brooks3 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenomicsGene ExpressionMolecularPathway InteractionsCellsTumorResearch PersonnelBaseTissuesSignal TransductionSpecimenPathogenesisMutationProgramsInsightFutureTargeted TreatmentOverexpressionAreaGeneticGrowthUniversitiesMedical
Grant awards (44)
Fibroblast subsets in BPH pathogenesis$322,931
U54 · FY2025 · DK · contact PI
Fibroblast subsets in BPH pathogenesis$329,227
U54 · FY2024 · DK · contact PI
Fibroblast subsets in BPH pathogenesis$332,116
U54 · FY2023 · DK · contact PI
Fibroblast subsets in BPH pathogenesis$332,295
U54 · FY2022 · DK · contact PI
BMP5 cells and signaling in BPH pathogenesis$236,550
R01 · FY2022 · DK · contact PI
Genetic Predictors of Ameloblastoma Behavior$436,815
R01 · FY2021 · DE · contact PI
Fibroblast subsets in BPH pathogenesis$333,981
U54 · FY2021 · DK · contact PI
BMP5 cells and signaling in BPH pathogenesis$236,550
R01 · FY2021 · DK · contact PI
Genetic Predictors of Ameloblastoma Behavior$464,469
R01 · FY2020 · DE · contact PI
BMP5 cells and signaling in BPH pathogenesis$236,550
R01 · FY2020 · DK · contact PI
Genetic Predictors of Ameloblastoma Behavior$472,317
R01 · FY2019 · DE · contact PI
Genetic Predictors of Ameloblastoma Behavior$476,923
R01 · FY2018 · DE · contact PI
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer$333,147
R01 · FY2018 · CA · contact PI
Genetic Predictors of Ameloblastoma Behavior$511,525
R01 · FY2017 · DE · contact PI
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer$333,139
R01 · FY2017 · CA · contact PI
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer$333,133
R01 · FY2016 · CA · contact PI
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer$333,127
R01 · FY2015 · CA · contact PI
Administrative Core$93,027
P20 · FY2015 · DK · contact PI
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer$333,122
R01 · FY2014 · CA · contact PI
Tissue Procurement$106,436
P30 · FY2014 · CA · contact PI
Administrative Core$93,027
P20 · FY2014 · DK · contact PI
Tissue Procurement$66,921
P30 · FY2013 · CA · contact PI
Tissue Procurement$71,504
P30 · FY2012 · CA · contact PI
Tissue Procurement$73,170
P30 · FY2011 · CA · contact PI
Gene Amplification and Deletion in Pancreatic Cancer$271,945
R01 · FY2010 · CA · contact PI
Pathogenetics of a Clinically-favorable Prostate Cancer Subtype$206,190
R01 · FY2010 · CA · contact PI
Tissue Procurement$82,359
P30 · FY2010 · CA · contact PI
Molecular Characterization of Sporadic Colorectal Cancer in the Young from India$32,486
R03 · FY2010 · TW · contact PI
Gene Amplification and Deletion in Pancreatic Cancer$271,856
R01 · FY2009 · CA · contact PI
Pathogenetics of a Clinically-favorable Prostate Cancer Subtype$206,190
R01 · FY2009 · CA · contact PI
Tissue Procurement Facility$45,689
P30 · FY2009 · CA · contact PI
Molecular Characterization of Sporadic Colorectal Cancer in the Young from India$32,486
R03 · FY2009 · TW · contact PI
Gene Amplification and Deletion in Pancreatic Cancer$271,769
R01 · FY2008 · CA · contact PI
Pathogenetics of a Clinically-favorable Prostate Cancer Subtype$206,190
R01 · FY2008 · CA · contact PI
Tissue Procurement Facility$43,211
P30 · FY2008 · CA · contact PI
Molecular Characterization of Sporadic Colorectal Cancer in the Young from India$39,648
R03 · FY2008 · TW · contact PI
Role of Gene Amplification in Breast Cancer$313,047
R01 · FY2007 · CA · contact PI
Gene Amplification and Deletion in Pancreatic Cancer$271,685
R01 · FY2007 · CA · contact PI
Tissue Procurement Facility$35,540
P30 · FY2007 · CA · contact PI
Role of Gene Amplification in Breast Cancer$322,340
R01 · FY2006 · CA · contact PI
Gene Amplification and Deletion in Pancreatic Cancer$293,668
R01 · FY2006 · CA · contact PI
Role of Gene Amplification in Breast Cancer$329,332
R01 · FY2005 · CA
Role of Gene Amplification in Breast Cancer$329,324
R01 · FY2004 · CA
Role of Gene Amplification in Breast Cancer$339,075
R01 · FY2003 · CA